GRST ETHEMA HEALTH Corp revenue, earnings and financials
For the quarter ended December 31, 2025, ETHEMA HEALTH Corp reported revenue of $4.81M (up 228.0% from a year earlier), net income of −$1.06M and diluted EPS of $0.00; over the last four quarters revenue was $18.8M and net income −$2.18M; for the fiscal year ended December 2025 revenue was $18.8M, up 211.9% on the year before.
GRST annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $18.8M, gross profit n/a, operating income −$260K, net income −$2.18M (margin -11.6%), EPS $0.00
- Fiscal year ended Dec 2024: revenue $6.02M, gross profit n/a, operating income −$1.33M, net income −$2.06M (margin -34.3%), EPS $0.00
- Fiscal year ended Dec 2023: revenue $5.34M, gross profit n/a, operating income −$542K, net income $1.01M (margin 18.8%), EPS $0.00
- Fiscal year ended Dec 2022: revenue $4.82M, gross profit n/a, operating income $489K, net income $295K (margin 6.1%), EPS n/a
- Fiscal year ended Dec 2021: revenue $1.94M, gross profit n/a, operating income $2.11K, net income −$1.54M (margin -79.4%), EPS n/a
GRST quarterly revenue and earnings
- Quarter ended Dec 31, 2025 (from the annual report): revenue $4.81M (up 228.0% year over year), net income −$1.06M, EPS $0.00
- Quarter ended Sep 30, 2025: revenue $5.53M (up 214.2% year over year), net income $66.1K, EPS $0.00
- Quarter ended Jun 30, 2025: revenue $4.91M (up 229.2% year over year), net income −$296K, EPS $0.00
- Quarter ended Mar 31, 2025: revenue $3.52M (up 170.6% year over year), net income −$885K, EPS $0.00
- Quarter ended Dec 31, 2024 (from the annual report): revenue $1.47M (up 30.4% year over year), net income −$326K, EPS $0.00
- Quarter ended Sep 30, 2024: revenue $1.76M (up 30.0% year over year), net income −$1.00M, EPS $0.00
- Quarter ended Jun 30, 2024: revenue $1.49M (down 4.8% year over year), net income −$363K, EPS $0.00
- Quarter ended Mar 31, 2024: revenue $1.30M (up 0.0% year over year), net income −$374K, EPS $0.00
- Quarter ended Dec 31, 2023 (from the annual report): revenue $1.13M (down 8.9% year over year), net income −$1.16M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $1.35M (down 5.0% year over year), net income $2.11M, EPS $0.00
- Quarter ended Jun 30, 2023: revenue $1.57M (up 37.6% year over year), net income $232K, EPS $0.00
- Quarter ended Mar 31, 2023: revenue $1.30M (up 27.0% year over year), net income −$176K, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue $1.23M (up 38.8% year over year), net income $128K, EPS n/a
- Quarter ended Sep 30, 2022: revenue $1.42M (up 64.5% year over year), net income $512K, EPS $0.00
- Quarter ended Jun 30, 2022: revenue $1.14M (up 1083.5% year over year), net income −$180K, EPS n/a
- Quarter ended Mar 31, 2022: revenue $1.02M (up 1027.1% year over year), net income −$165K, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $889K, net income $1.92M, EPS n/a
- Quarter ended Sep 30, 2021: revenue $866K, net income $1.53M, EPS $0.00
- Quarter ended Jun 30, 2021: revenue $96.2K, net income −$2.63M, EPS $0.00
- Quarter ended Mar 31, 2021: revenue $90.8K, net income −$2.37M, EPS $0.00
GRST cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$32.9K, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$456K, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$530K, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow $1.58M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$85.6K, share buybacks n/a
GRST balance sheet
- Dec 31, 2025: cash $59.5K, total assets $28.8M, total liabilities $38.4M, shareholders' equity −$9.64M
- Sep 30, 2025: cash $114K, total assets $30.3M, total liabilities $38.8M, shareholders' equity −$8.57M
- Jun 30, 2025: cash $442K, total assets $28.9M, total liabilities $37.5M, shareholders' equity −$8.64M
- Mar 31, 2025: cash $210K, total assets $28.5M, total liabilities $36.9M, shareholders' equity −$8.34M
- Dec 31, 2024: cash $245K, total assets $12.2M, total liabilities $19.6M, shareholders' equity −$7.46M
- Sep 30, 2024: cash $60.9K, total assets $12.3M, total liabilities $19.5M, shareholders' equity −$7.13M
- Jun 30, 2024: cash $31.1K, total assets $12.3M, total liabilities $20.5M, shareholders' equity −$8.14M
- Mar 31, 2024: cash $137K, total assets $11.6M, total liabilities $18.1M, shareholders' equity −$6.57M
What is GRST's revenue?
ETHEMA HEALTH Corp reported $18.8M of revenue over its last four quarters, through December 31, 2025.
Is GRST profitable?
No. ETHEMA HEALTH Corp lost $2.18M over the last four quarters.
What is GRST's EPS?
Diluted earnings per share over the last four quarters were $0.00; $0.00 in the latest quarter.